It's a question of valuation. This is micro/small cap and this...

It's a question of valuation. This is micro/small cap and this end of the market is about buying on potential.

If it was to decrease, it would be for the reasons friendlydwarves mentioned. He is suggesting the potential effects of dilution due to the disconnect between current SP and CR. To sum up he is suggesting the value of each share has reduced as the PLP MC is not keeping pace.

I am suggesting PLP with Lepidico deal going through is essentially under-valued so that each share now and potentially issued is worth more. I am also suggesting the disconnect in SP vs CR is an enticement to enter the market.

Overall, IMO if this was to be the market's issue it would have been sold down ages ago to a price that is more aligned to the CR offer. We have all witnessed tenements, 2 JVs (with potentially more to come) and the acquisition of Lepidico, hence my reasoning that this is worth more than the effects of any CR. The CR is an enticement IMO